Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study - Kolb, S J; Coffey, C S; Yankey, J W (Ann Clin Transl Neurol, 2016)
, et al; NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators.